Temporal flux in β-lactam resistance among Klebsiella pneumoniae in Western Australia
Authors:
- 1 May 2016
- journal article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 65 (5) , 429-437
Abstract
Our aim was to identify long term beta-lactam resistance trends in local K. pneumoniae isolates, which are a common cause of sepsis in Western Australia. We studied three collections of K. pneumoniae isolates from Western Australia between 1977 and 2015 comprising contemporary blood culture (98), multi-resistant (21) and historical (50) isolates. Antimicrobial resistance was determined by CLSI agar dilution methods. PCR DNA sequencing identified beta-lactamase variants and porin mutations contributing to beta-lactam resistance. Isolates were genotyped by PFGE, MLST and a variable number tandem repeat (VNTR) method. From 1989 onwards we detected the SHV-2a extended spectrum beta-lactamase (ESBL) in ceftriaxone-resistant isolates, and in ceftazidime- and aztreonam- resistant isolates from 1993. Ceftriaxone, ceftazidime and aztreonam resistance persisted, with blaCTX-M types becoming the dominant ESBLs by 2010. CTX-M-15 was encountered in both multi-resistant and blood culture isolates. Meropenem resistance was detected for the first time in 2011 in a locally isolated blaIMP-4-positive K. pneumoniae. We found sequence types (STs) 23 and 86 that occurred in multiple isolates from invasive infections. ST86 was the most common and maintained a high degree (90%) of similarity by PFGE since 1977. Ceftazidime-resistant K. pneumoniae sequence types have caused invasive infections in Western Australia since 1993. Invasive isolates producing CTX-M-14 and CTX-M-15 appeared in Western Australia during the last decade, before the appearance of carbapenemases. The diversity of beta-lactam resistance and beta-lactamase resistance mechanisms in Western Australian K. pneumoniae has increased since ESBLs were first locally described.Keywords
This publication has 37 references indexed in Scilit:
- Managing a nosocomial outbreak of carbapenem‐resistant Klebsiella pneumoniae: an early Australian hospital experienceInternal Medicine Journal, 2015
- Genomic Definition of Hypervirulent and Multidrug-Resistant Klebsiella pneumoniae Clonal GroupsEmerging Infectious Diseases, 2014
- Whole Genome Sequence Analysis of the First Australian OXA-48-Producing Outbreak-Associated Klebsiella pneumoniae Isolates: The Resistome and In Vivo EvolutionPLOS ONE, 2013
- CTX-M Enzymes: Origin and DiffusionFrontiers in Microbiology, 2012
- Emerging Severe and Fatal Infections Due to Klebsiella pneumoniae in Two University Hospitals in FranceJournal of Clinical Microbiology, 2011
- Early Dissemination of NDM-1- and OXA-181-Producing Enterobacteriaceae in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007Antimicrobial Agents and Chemotherapy, 2011
- Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in EnterobacteriaceaeJournal of Antimicrobial Chemotherapy, 2010
- Evidence for Clonal Dissemination of the Serotype K1 Klebsiella pneumoniae Strain Causing Invasive Liver Abscesses in KoreaJournal of Clinical Microbiology, 2008
- Multilocus Sequence Typing of Klebsiella pneumoniae Nosocomial IsolatesJournal of Clinical Microbiology, 2005
- Chromosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1989